Jorgelina M Calandria

5PUBLICATIONS
8CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsNanoelectromechanical systemsMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 23, 2025
ELV-N34, RvD6-Isomer, or NPD1 Halt Replication of SARS-CoV-2 Omicron BA.5 Virus in Human Lung and Nasal Cells.

Jorgelina M Calandria, Haydee E P Bazan, Surjyadipta Bhattacharjee

|Dec 12, 2023
Elovanoid-N34 modulates TXNRD1 key in protection against oxidative stress-related diseases.

Jorgelina M Calandria, Surjyadipta Bhattacharjee, Sayantani Kala-Bhattacharjee

|Jun 10, 2022
Targeting lipid metabolism in cancer: neuroblastoma.

Massimiliano Agostini, Gerry Melino, Bola Habeb

|Jan 21, 2022
Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.

Francesco Rugolo, Nicolas G Bazan, Jorgelina Calandria

|Aug 01, 2021
The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.

Francesco Rugolo, Nicolas G Bazan, Jorgelina Calandria

Pageof 1

Frequent Collaborators

5 joint publications

Nicolas G Bazan

3 joint publications

Gerry Melino

3 joint publications

Massimiliano Agostini

2 joint publications

Francesco Rugolo